Skip to content

CDR

Mobile shopping options grow at CVS

With a recent study from IBM showing the percentage of consumers using mobile devices to shop has nearly tripled over the past year, CVS/pharmacy has made its entire cvs.com catalog available through its mobile site.

Outlook for biopharmaceutical sector is bright

patent cliffs, stagnant pipelines, the end of the blockbuster era, etc. In reality, the prospects of the biopharmaceutical sector — for patients in search of new medicines, for policy makers seeking value in the health care system and for

2011 Holiday Sales: Not much cheer for drug chains

2011 Holiday Sales: Not much cheer for drug chains

Absent the last-minute shopping surge that rescued holiday sales a year ago, Christmas 2011 was in the main a dismal event for the nation’s drug chains. The holiday shopping season that began on Black Friday, Nov. 25, and ended 30 days later on Christmas Eve — giving the retail community one more

Mylan ships pair of new generics

Mylan Inc. has announced the rollout of two new generic drugs, including medications for high blood pressure and epilepsy. The company said Tuesday that its subsidiary Mylan Pharmaceuticals Inc.

Walgreens brings new format to D.C.

Walgreen Co.’s new "health and daily living store" concept has made its debut in Washington, D.C., and the drug chain plans more of the new-format stores in that market.

Pharmacy techs serve up FSA advice

Retail pharmacy teams, including pharmacy technicians, are offering practical solutions to patients about how to best use remaining 2011 flexible spending account (FSA) funds, according to the Pharmacy Technician Certification Board (PTCB).

Amneal rolls out generic Felbamate suspension

Amneal Pharmaceuticals has launched what it said is the first generic Felbamate oral suspension in 600 mg/5 ml strength. Amneal said Wednesday that the first-to-market product is an AB-rated, therapeutically equivalent alternative to Meda Pharmaceuticals’ Felbatol.